An in vivo propagated human acute myeloid leukemia expressing ABCA3

Leukemia Research

Volumn 28, Issue 3, 2004, Pages 295-299

  Norwood, Kevin ^a   Wang, Rui Yu ^b   Hirschmann Jax, Charlotte ^a   Andreeff, Michael ^b   Brenner, Malcolm K ^a   Goodell, Margaret A ^a   Wulf, Gerald G ^c  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute myeloid leukemia; Human AML cell line; Xenotransplantation

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; BREAST CANCER RESISTANCE PROTEIN; MITOCHONDRIAL RIBOSOMAL PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL MODEL; ARTICLE; BLAST CELL; CASE REPORT; CELL POPULATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; XENOTRANSPLANTATION;

EID: 0347626017     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.08.006     Document Type: Article

References (23)

1. Fialkow P.J., Singer J.W., Adamson J.W., Vaidya K., Dow L.W., Ochs J.et al. Acute nonlymphocytic leukemia: heterogeneity of stem cell origin. Blood. 57:1981;1068-1073.
2. Keinanen M., Griffin J.D., Bloomfield C.D., Machnicki J., de la Chapelle A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. New Engl. J. Med. 318:1988;1153-1158.
3. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:1997;730-737.
4. Wulf G.G., Wang R.Y., Kuehnle I., Weidner D., Marini F., Brenner M.K.et al. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood. 98:2001;1166-1173.
5. Terpstra W., Prins A., Ploemacher R.E., Wognum B.W., Wagemaker G., Lowenberg B.et al. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood. 87:1996;2187-2194.
6. Blair A., Hogge D.E., Sutherland H.J. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR. Blood. 92:1998;4325-4335.
7. Ailles L.E., Gerhard B., Kawagoe H., Hogge D.E. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood. 94:1999;1761-1772.
8. Dick J.E. Human stem cell assays in immune-deficient mice. Curr. Opin. Hematol. 3:1996;405-409.
9. Beran M., Pisa P., Kantarjian H., Porwit A., Bjorkholm M. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice. Hematol. Pathol. 8:1994;135-154.
10. Nishi N., Ishikawa R., Inoue H., Nishikawa M., Yoneya T., Kakeda M.et al. In vitro long-term culture of human primitive hematopoietic cells supported by murine stromal cell line MS-5. Leukemia. 11(Suppl 3):1997;468-473.
11. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1996;1797-1806.
12. Engel H., Drach J., Keyhani A., Jiang S., Van N.T., Kimmel M.et al. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells. Leukemia. 13:1999;568-577.
13. Errecalde A.L., Garcia A.L., Inda A.M., Badran A.F. G2 restriction point within populations of hepatocytes and tongue keratinocytes in young, growing mice. Cell Biol. Int. 22:1998;359-362.
14. Seabright M. A rapid banding technique for human chromosomes. Lancet. 2:1971;971-972.
15. Boutonnat J., Bonnefoix T., Mousseau M., Seigneurin D., Ronot X. Coexpression of multidrug resistance involve proteins: a flow cytometric analysis. Anticancer Res. 18:1998;2993-2999.
16. Nicolson G.L. Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metastasis Rev. 3:1984;25-42.
17. Bunting K.D., Galipeau J., Topham D., Benaim E., Sorrentino B.P. Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture. Ann. N.Y. Acad. Sci. 872:1999;125-140. [discussion 140-121].
18. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J.et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7:2001;1028-1034.
19. Leith C.P., Kopecky K.J., Chen I.M., Eijdems L., Slovak M.L., McConnell T.S.et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood. 94:1999;1086-1099.
20. Ross D.D., Karp J.E., Chen T.T., Doyle L.A. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood. 96:2000;365-368.
21. Connors T.D., Van Raay T.J., Petry L.R., Klinger K.W., Landes G.M., Burn T.C. The cloning of a human ABC gene (ABCA3) mapping to chromosome 16p13.3. Genomics. 39:1997;231-234.
22. Klugbauer N., Hofmann F. Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance-associated protein. FEBS Lett. 391:1996;61-65.
23. Broccardo C., Luciani M., Chimini G. The ABCA subclass of mammalian transporters. Biochim. Biophys. Acta. 1461:1999;395-404.